1. Home
  2. LZ vs PRCT Comparison

LZ vs PRCT Comparison

Compare LZ & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LegalZoom.com Inc.

LZ

LegalZoom.com Inc.

N/A

Current Price

$4.49

Market Cap

1.0B

Sector

Technology

ML Signal

N/A

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

N/A

Current Price

$25.08

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LZ
PRCT
Founded
2001
2009
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
LZ
PRCT
Price
$4.49
$25.08
Analyst Decision
Hold
Hold
Analyst Count
7
15
Target Price
$6.38
★ $22.75
AVG Volume (30 Days)
★ 2.5M
1.2M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.71
EPS
★ 0.08
N/A
Revenue
★ $756,043,000.00
$308,054,000.00
Revenue This Year
$5.76
$28.23
Revenue Next Year
$3.70
$19.82
P/E Ratio
$57.06
★ N/A
Revenue Growth
10.88
★ 37.22
52 Week Low
$4.50
$16.67
52 Week High
$10.51
$38.11

Technical Indicators

Market Signals
Indicator
LZ
PRCT
Relative Strength Index (RSI) 29.63 67.11
Support Level N/A $24.85
Resistance Level $6.65 $26.41
Average True Range (ATR) 0.38 1.66
MACD -0.13 0.34
Stochastic Oscillator 0.73 78.65

Price Performance

Historical Comparison
LZ
PRCT

About LZ LegalZoom.com Inc.

LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: